Emitefur
Emitefur is an orally active and potent anticancer drug. Emitefur can be used for advanced gastric cancer patients[1].
Product Specifications
CAS Number
110690-43-2
Product Name Alternative
BOF-A2
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emitefur.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC(C(N(C2=O)C(N(C=C2F)COCC)=O)=O)=C1)OC3=NC(OC(C4=CC=CC=C4)=O)=CC=C3C#N
Molecular Formula
C28H19FN4O8
Molecular Weight
558.47
References & Citations
[1]Sugimachi K, et al. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer. Surg Today. 2000;30 (12) :1067-72.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC883393-100 1x 100 µL
Drebrin 1 (DBN1) (DBN1/3393), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-P139910-5MG 5 mg
Palbociclib N-Beta-D-Glucuronide Sodium Salt (Technical Grade, ~65%)
Sign In for Pricing
View Details 
